International CongresseseuroPCR 2013 .

euroPCR 2013 .

solaci
solaci
296
0

The most relevant articles and presentations, daily report from the euroPCR 2013 – May, 21 to 24.

If you cannot view the articles, click here

Previous article
Aortic Valvuloplasty in the transcatheter aortic valve implantation era 
Next article
QRS after TAVI, The Best Predictor for safe transitory pacemaker removal
solaci
solaci

More articles by this author

EuroPCR 2024

solaci - 0
Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

solaci - 0
Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

solaci - 0
Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

solaci - 0
Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

EuroPCR 2024

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here
solaci -
SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Dr. Omar Tupayachi - 0
Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Dr. Omar Tupayachi - 0
Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

Dr. Omar Tupayachi - 0
The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...